Pine Tree Equity Recapitalizes Marshall & Stevens

Pine Tree Equity Recapitalizes Shortridge Academy

October 1, 2019

Education

Pine Tree Equity IV, LP recapitalized Shortridge Academy Ltd in October 2019, partnering with the company's founding entrepreneur. The recapitalization will support Shortridge's geographic expansion and enable pursuit of complementary add-on acquisitions as a platform investment.

Pine Tree Equity Recapitalizes iCare Health Solutions

January 1, 2020

Healthcare Services

Pine Tree Equity IV, LP recapitalized iCare Health Solutions (and affiliated entities) in January 2020, partnering with the company's founder and management team. The recapitalization is intended to accelerate iCare's geographic expansion across Florida and support complementary add-on acquisitions to grow its managed vision benefits and provider network business.

Pine Tree Equity Recapitalizes Summit Health Pharmacy

December 1, 2021

Healthcare Services

Pine Tree Equity IV, LP recapitalized Summit Health Pharmacy, LLC in December 2021, partnering with the existing management team to support the company's growth. Summit, headquartered in Brookhaven, Pennsylvania and founded in 1995, is a specialty compounding pharmacy focused on rare pediatric metabolic medications; the recapitalization is intended to accelerate geographic expansion and enable complementary add-on acquisitions.

Pine Tree Equity Recapitalizes Paradigm Treatment Centers

April 1, 2019

Healthcare Services

Pine Tree Equity III, LP recapitalized Paradigm Treatment Centers, LLC in April 2019. The recapitalization partners Pine Tree with the founders to accelerate Paradigm's geographic expansion and pursue complementary add-on acquisitions; Paradigm is a Malibu, California–headquartered provider of residential and behavioral health treatment programs for adolescents.

Pine Tree Equity Recapitalizes Chemistry Rx

March 1, 2021

Healthcare Services

Pine Tree Equity IV, LP recapitalized Madame Rx, LLC d/b/a Chemistry Rx in March 2021, partnering with the founder and management team. The recapitalization will support Chemistry Rx’s geographic expansion and enable pursuit of complementary add-on acquisitions to grow the compounding and specialty pharmacy platform.

Coalesce Capital Majority Recapitalizes Marshall & Stevens

January 6, 2026

Professional Services

Coalesce Capital announced a majority recapitalization of Marshall & Stevens, a leading independent valuation, litigation support, and transaction advisory firm. Management will retain a meaningful ownership stake and Coalesce will support growth through investments in talent, technology, and strategic acquisitions; the transaction closed in December 2025.